Low molecular weight peptidomimetic growth hormone secretagogues
US6034216A · kind A · utility
3Cited by
21References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 8, 1998 |
| Grant date | Mar 7, 2000 |
| Priority date | — |
| Expiry date | Apr 8, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention comprises growth hormone releasing peptides/peptidomimetics (GHRP) capable of causing release of growth hormone from the pituitary. Compositions containing the GHRP's of this invention are used to promote growth in mammals either alone or in combination with other growth promoting compounds, especially IGF-1. In a method of this invention GHRP's in combination with IGF-1 are used to treat Type II diabetes. An exemplary compound of this invention is provided below. ##STR1##
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.